In this video, I'll be recreating the popular demonstration called the Chemical Traffic Light Reaction. Note: I made a ...
Chemists have developed a light-driven method for producing a rare and highly strained molecular structure known as “housane.” Designing a new drug often starts with a basic but difficult task: making ...
Technologies that convert carbon dioxide (CO₂) emitted from factories and power plants into useful chemical feedstocks are considered key to achieving carbon neutrality. However, rapid degradation of ...
Researchers have developed a new eco friendly method to transform biochar into a highly hydrophobic material that can repel water and absorb large ...
Instead of treating plastic purely as waste, new research shows that it can be transformed into something useful — acetic acid, a key component of vinegar and an important industrial chemical.
WISN 12 News on MSN

Hazmat scare at hospital

Western Lakes Fire District called to Aurora Summit for a Hazmat response.
Crews responded to a hazardous materials incident at Aurora Advocate Hospital Summit on Wednesday, March 11, but officials say the chemical reaction was contained and no injuries or exposure were ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals—a discovery that could accelerate and improve how medicines ...
“At the early stage, you’ve got to be hands-on, get involved with everything and everyone, and really understand your own limitations,” he added. For emerging biotechs, this combination of strategic ...
Pharmaceutical Technology on MSN

Eli Lilly finds impurity in compounded tirzepatide

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.
By Leah Douglas WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lilly's Zepbound could present health risks to consumers due to a ...
Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...